Test Price
2,800 AED✅ Home Collection Available
MPZ Gene (CMT2I) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015, Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Laboratory: DNA Labs UAE – DHA Facility License No. 1143, Dubai Healthcare City.
Test Overview & Methodology
The MPZ Gene (CMT2I) Genetic Test identifies pathogenic variants in the myelin protein zero gene responsible for Charcot-Marie-Tooth disease type 2I, a progressive hereditary neuropathy. This advanced Next-Generation Sequencing analysis provides definitive molecular diagnosis for at-risk individuals, enabling early intervention and family planning.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Standard Panel) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity, full gene NGS with copy number analysis | 95% sensitivity, limited to hotspot regions only |
| Methodology | Next-Generation Sequencing (NGS) + Sanger confirmation | Targeted genotyping or Sanger only |
| Turnaround Time | 3-4 Weeks (express options available) | 6-8 Weeks |
Physician Insight & Safety Protocols
“This genetic test is a powerful tool, but it must be interpreted within the full clinical picture. A negative result does not exclude other neuropathies, and a positive finding guides management but requires genetic counselling to understand implications for family.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Advisory: Medication & Clinical Precautions
⚠️ Important: Never discontinue prescribed neurological medications without consulting your physician. This test is a diagnostic adjunct and does not replace ongoing medical supervision. Always discuss result implications with a qualified healthcare provider before altering treatment.
Safety Exclusion Criteria & Emergency Red Flags
- Individual unable to provide informed consent (unless parent/guardian for minors).
- Recent blood transfusion (within 4 weeks) may affect germline DNA extraction.
- Severe acute illness requiring hospitalization – postpone elective testing.
- ER Red Flags: If you experience sudden worsening of muscle weakness, breathing difficulty, or severe swallowing problems, go to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What is the MPZ CMT2I genetic test, and why might I need it?
This test analyses the MPZ gene using Next-Generation Sequencing to confirm or rule out Charcot-Marie-Tooth disease type 2I when clinical symptoms or family history suggest a hereditary neuropathy. It identifies specific mutations responsible for the condition, enabling precise diagnosis and guiding treatment and family planning decisions. Early detection can help initiate physical therapy, orthopaedic monitoring, and genetic counselling for relatives.
2. How is the sample collected, and is there any special preparation?
A simple blood draw is collected by a licensed phlebotomist via our VIP Mobile Phlebotomy service. Genetic counselling is mandatory before testing to understand your family health history. No fasting is required, but you must provide any previous neurological reports. Our cold-chain logistics preserve sample integrity from collection to the ISO-certified laboratory. Available daily from 8 AM to 11 PM.
3. When will I receive my results, and how will they be explained?
Results are finalized within 3–4 weeks and are delivered through a secure portal, followed by a telephonic explanation from a DHA-licensed genetic counsellor to discuss clinical implications and next steps. Your report will indicate whether a disease-causing variant was found, clarify carrier status, and provide recommendations for specialist follow-up. All data is protected under UAE PDPL laws and stored encrypted.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Compliance
Your personal data and genetic information are fully protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and managed in compliance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is licensed by the Dubai Health Authority (DHA License No. 1143) and operates from Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | MPZ Gene (CMT2I) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3-4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL in EDTA tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | G60.0 |
| LOINC Code | 74421-8 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians